May 9, 2011
Press Availability - Thursday May 12, 2011 at 9:00 a.m.
Press Availability - Thursday May 12, 2011 at 9:00 a.m.
Dr. Reuben Shaw and Dr. Marc Montminy, both of Salk’s Helmsley Center for Nutritional Genomics, will be presenting two research studies disclosing critical discoveries in the area of diabetes and metabolism.
Together, their studies reveal that so called HDACs (histone deacetylases), a group of enzymes that is the target of the latest generation of cancer drugs, play a central role in controlling the body’s energy balance and that HDAC inhibitors may provide a novel way to cut excessive blood glucose level at the source.
|
Who: |
Dr. William R. Brody, President of the Salk Institute Dr. Marc Montminy, Professor in the Clayton Foundation Laboratories for Peptide Biology. Dr. Reuben Shaw, Howard Hughes Medical Institute Early Career scientist, Hearst Endowment Assistant Professor, Assistant Professor in Molecular and Cell Biology Laboratory Dr. Ronald M. Evans, Howard Hughes Medical Institute Investigator Professor, Professor of Gene Expression Laboratory, March of Dimes Chair in Molecular and Developmental Biology |
|
Why: |
Dr. Reuben Shaw and Dr. Marc Montminy, both of Salk’s Helmsley Center for Nutritional Genomics, will be presenting two research studies disclosing critical discoveries in the area of diabetes and metabolism. Dr. Montminy revealed how insulin increases fat storage during feeding in fruit flies. Dr. Shaw discovered a novel “fasting pathway” that points the way to a new class of diabetes drugs that can restore abnormally high blood glucose level to normal. Together, their studies reveal that so called HDACs (histone deacetylases), a group of enzymes that is the target of the latest generation of cancer drugs, play a central role in controlling the body’s energy balance and that HDAC inhibitors may provide a novel way to cut excessive blood glucose level at the source. Information strictly embargoed until May 12, 2011, 12 noon US EST Although the findings are the result of separate research efforts, it was the uniquely collaborative and targeted approach taken by members of the Salk Center for Nutritional Genomics that made this success story possible. The Center for Nutritional Genomics was founded two years ago with a $5.5 million grant from the Leona M. and Harry B. Helmsley Charitable Trust. |
|
What: |
Short presentations to announce findings by panelists followed by Q&A session. |
|
When: |
Begins promptly at 9:00 am, Thursday, May 12, 2011 |
|
Where: |
索尔克生物研究所 Trustee’s Room 10010 North Torrey Pines Rd La Jolla, California 92037 (The Trustee’s Room is located on the 1st floor in Southeast building) |
|
How: |
TO COVER THESE ANNOUNCEMENTS AND TALK TO THE SCIENTISTS: Attend In Person: RSVP to reserve a place at the discussion to be held in the Trustee’s Room at the Salk Institute for Biological Studies. (Parking and directions available upon request) Online Viewing/Participation: Phone Participation: 1 – Dial the toll-free number: 888-387-8686 (International callers: 001-720-259 -0759) Questions can submitted ahead of time via twitter by tweeting @salkinstitute and using the hashtag #salkdiabetes or sending them via email to communications@salk.edu |
关于索尔克生物研究所：
索尔克生物研究所是世界顶尖的基础研究机构之一，其国际知名的教职人员在一个独特、协作和富有创造性的环境中，深入探究生命科学的基本问题。索尔克科学家们致力于发现和指导未来几代研究人员，通过研究神经科学、遗传学、细胞和植物生物学以及相关学科，在癌症、衰老、阿尔茨海默氏症、糖尿病和传染病的认识方面做出了开创性的贡献。.
学院取得了许多成就，获得了包括诺贝尔奖和美国国家科学院院士在内的无数荣誉。该研究所由脊髓灰质炎疫苗先驱 Jonas Salk 博士于 1960 年创立，是一家独立的非营利组织和建筑地标。.
宣传办公室
电话：(858) 453-4100
press@salk.edu
